heart.jpgIPNews® – The Federal Circuit on Tuesday ruled that a lower court was wrong to find Medtronic Inc. did not infringe two patents for a heart implant device held by a company that licensed the patents to a Boston Scientific Corp. unit.

The appeals court remanded the matter for further proceedings, saying the district court relied on a legally incorrect allocation of the burden of proof to find noninfringement in the limited circumstances of the case. The district court also incorrectly construed the claim terms in question, though, as Medtronic had argued on appeal, the appeals court said. To continue reading, click: Federal Circuit Overturns Noninfringement Finding In Medtronic Heart Patent Case